Investor Overview

Webcast ImageWebcast
Verastem Inc at the 2015 UBS Global Healthcare Conference  (Replay)
05/19/15 at 1:30 p.m. ET
Verastem Inc at the 2015 UBS Global Healthcare Conference
Tuesday, May 19, 2015 1:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Verastem Analyst Breakfast at ASCO (Live)
05/31/15 at 6:30 a.m. CT
Verastem Analyst Breakfast at ASCO
Sunday, May 31, 2015 6:30 a.m. CT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Corporate Profile
Verastem, Inc. (NASDAQ: VSTM) is a clinical-stage biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. Cancer stem cells are an underlying cause of tumor recurrence and metastasis. Verastem is developing small molecule inhibitors of signaling pathways that are critical to cancer stem cell survival and proliferation: FAK, PI3K/mTOR and Wnt.
Stock Quote
VSTM (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$8.67
Change (%) Stock is Up 0.25 (2.97%)
Volume396,425
Data as of 05/22/15 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent News More >>
DateTitle 
05/19/15Verastem Announces Analyst Event and Webcast at the 2015 ASCO Annual Meeting
- Guest Speakers to Give Presentations on Mesothelioma and Rationale for Targeting Cancer Stem Cells through FAK Inhibition - BOSTON--(BUSINESS WIRE)--May 19, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will host an analyst and investor event on Sunday, May 31st at the 2015 American Society of Clinical Oncology (A... 
Printer Friendly Version
05/12/15Verastem to Present at 2015 UBS Global Health Care Conference
BOSTON--(BUSINESS WIRE)--May 12, 2015-- Verastem, Inc. (NASDAQ: VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will present at the 2015 UBS Global Healthcare Conference on Tuesday, May 19 at 1:30 p.m. ET at the Sheraton New York Times Square Hotel in New York City. A live webcast of the presentation will be available on the company's website ... 
Printer Friendly Version
05/11/15Verastem Reports First Quarter 2015 Financial and Corporate Results
— COMMAND Interim Analysis Anticipated in Third Quarter 2015 — BOSTON--(BUSINESS WIRE)--May 11, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the first quarter ended March 31, 2015, and also provided an overview of certain corporate accomplishments and plans. “The team continues to efficiently execute on... 
Printer Friendly Version
04/30/15Verastem to Present at Upcoming Investor Conferences
BOSTON--(BUSINESS WIRE)--Apr. 30, 2015-- Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced that the company will participate at the following upcoming investor conferences: Deutsche Bank 40th Annual Healthcare Conference on Wednesday, May 6, 2015 at 3:30 p.m. ET at the InterContinental Hotel in Boston Mizuho S... 
Printer Friendly Version
Receive E-mail AlertsE-mail Alert Icon
Sign up to receive e-mail alerts whenever Verastem Inc posts new information to the site. Just enter your e-mail address and click Submit.
 

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.